BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8680051)

  • 1. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment.
    Renlund DG; Gopinathan SK; Kfoury AG; Taylor DO
    Clin Transplant; 1996 Feb; 10(1 Pt 2):136-9. PubMed ID: 8680051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil for maintenance therapy in kidney transplantation.
    Gonwa TA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):128-30. PubMed ID: 8680049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
    Kobashigawa J; Miller L; Renlund D; Mentzer R; Alderman E; Bourge R; Costanzo M; Eisen H; Dureau G; Ratkovec R; Hummel M; Ipe D; Johnson J; Keogh A; Mamelok R; Mancini D; Smart F; Valantine H
    Transplantation; 1998 Aug; 66(4):507-15. PubMed ID: 9734496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of mycophenolate mofetil (MMF) in kidney transplantation: results of a single center trial].
    Pastural M; Barrou B; Golmard JL; Gorichon-Radideau E; Manighetti J; Ourahma S; Benalia H; Mouquet C; Chatelain C; Bitker MO
    Prog Urol; 1999 Feb; 9(1):19-25. PubMed ID: 10212949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil.
    Sollinger HW
    Kidney Int Suppl; 1995 Dec; 52():S14-7. PubMed ID: 8587275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mycophenolate mofetil in transplant recipients.
    Mele TS; Halloran PF
    Immunopharmacology; 2000 May; 47(2-3):215-45. PubMed ID: 10878291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue therapy with mycophenolate mofetil. Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Tomlanovich SJ
    Transplant Proc; 1996 Dec; 28(6 Suppl 1):34-6. PubMed ID: 8962412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine.
    Taylor DO; Sharma RC; Kfoury AG; Renlund DG
    Clin Transplant; 1999 Aug; 13(4):296-9. PubMed ID: 10485369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mycophenolate mofetil in heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC
    Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA
    Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients.
    Ensley RD; Bristow MR; Olsen SL; Taylor DO; Hammond EH; O'Connell JB; Dunn D; Osburn L; Jones KW; Kauffman RS
    Transplantation; 1993 Jul; 56(1):75-82. PubMed ID: 8333071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation.
    Annemans L; Lemkuhl H; Tenderich G; Schulz U; Yang XL; Ricci JF; Hetzer R
    Transplant Proc; 2007 Dec; 39(10):3306-12. PubMed ID: 18089377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil: suggested guidelines for use in kidney transplantation.
    Behrend M
    BioDrugs; 2001; 15(1):37-53. PubMed ID: 11437674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.